BB
BB Biotech Portfolio holdings
AUM
$3.98B
This Quarter Return
+5.05%
1 Year Return
+15.06%
3 Year Return
+120.36%
5 Year Return
+263.74%
10 Year Return
–
AUM
$2.53B
AUM Growth
+$2.53B
(+0.68%)
Cap. Flow
+$23M
Cap. Flow
% of AUM
0.91%
Top 10 Holdings %
Top 10 Hldgs %
72.66%
Holding
32
New
3
Increased
6
Reduced
2
Closed
2
Top Buys
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$27.2M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$16.9M |
| 3 |
MacroGenics
MGNX
|
$14M |
| 4 |
Agios Pharmaceuticals
AGIO
|
$8.52M |
| 5 |
Ionis Pharmaceuticals
IONS
|
$7.57M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
$35.6M |
| 2 |
INFI
Infinity Pharmaceuticals, Inc.
INFI
|
$14.2M |
| 3 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$10.1M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$6.3M |
Sector Composition
| 1 | Healthcare | 85.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACHN
26
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $9.98M | 0.39% |
1,279,340
| – | – |
|
27
Esperion Therapeutics
ESPR
$448M
| $9.96M | 0.39% |
1,008,542
| – | – |
|
28
PTC Therapeutics
PTCT
$3.92B
| $8.3M | 0.33% |
1,182,912
| – | – |
|
29
Cidara Therapeutics
CDTX
$1.66B
| $7.7M | 0.3% |
746,824
| – | – |
|
|
TBRA
30
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
| $5.88M | 0.23% |
+468,000
| New | +$5.88M |
|
|
INFI
31
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| – | – |
-2,700,737
| Closed | -$14.2M |
|
|
CLVS
32
DELISTED
Clovis Oncology, Inc.
CLVS
| – | – |
-528,188
| Closed | -$10.1M |
|